Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-
specific nature, causing harm to non-malignant tissues. Over the past several decades …

Over the past decades, great interest has been given to biomimetic nanoparticles (BNPs)
since the rise of targeted drug delivery systems and biomimetic nanotechnology. Biological …

Notwithstanding immune checkpoint blocking (ICB) therapy has made eminent clinical
breakthroughs, overcoming immunologically “cold” tumors remains challenging. Here, a …

Traditional tumor treatments, including chemotherapy, radiotherapy, photodynamic therapy,
and photothermal therapy, are developed and used to treat different types of cancer …

Given that type I photosensitizers (PSs) possess a good hypoxic tolerance, developing an
innovative tactic to construct type I PSs is crucially important, but remains a challenge …

Pharmacological activation of the stimulator of interferon genes (STING) pathway has
become a promising strategy for cancer immunotherapy. However, the insufficient tumorous …

The reactions of some structures to different external stimuli can be used for therapeutic
purposes. In particular, in photodynamic therapy (PDT), a light-sensitive compound or …

Here an excellent trimodality imaging‐guided synergistic photothermal therapy
(PTT)/photodynamic therapy (PDT)/chemodynamic therapy (CDT) is proposed. To this end …

Photodynamic therapy (PDT) has attained extensive attention as a noninvasive tumor
treatment modality. However, the hypoxia in solid tumors, skin phototoxicity of “always on” …

Glioblastoma (GBM) is one of the most challenging malignant brain tumors to treat. Herein,
we describe a nanoenzyme hemostatic matrix strategy with the tumor cavity in situ …